miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3Rounak Nassirpour, Min-Jean Yin|PLoS ONE|2013Cited by 102
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer CellsRounak Nassirpour, Min-Jean Yin|PLoS ONE|2013Cited by 93
Discovery of 1-{(3<i>R</i>,4<i>R</i>)-3-[({5-Chloro-2-[(1-methyl-1<i>H</i>-pyrazol-4-yl)amino]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR MutantsHengmiao Cheng, Ru Zhou, Deepak Dalvie et al.|Journal of Medicinal Chemistry|2016Cited by 93
Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer CellsSangita M. Baxi, Min-Jean Yin|PLoS ONE|2012Cited by 15